Literature DB >> 9236834

Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q.

A François1, J F Lesesve, A Stamatoullas, F Comoz, B Lenormand, I Etienne, I Mendel, J Hémet, C Bastard, H Tilly.   

Abstract

Two cases of peripheral T-cell lymphoma, characterized by hepatosplenic presentation and gamma/delta T-cell receptor phenotype on malignant cells, are reported. Little is known about the chromosomal changes in these peculiar lymphomas. We report the cytogenetic analysis of these two patients. Isochromosome 7q and trisomy 8 were observed. These abnormalities were reported previously in five cases of gamma/delta T-cell lymphoma. These two patients had lymphomatous infiltration of the spleen, liver, bone marrow, and (in one case) lymph nodes. These abnormalities occurred in immunocompromised patients (i.e., immunosuppressive therapy for kidney transplantation and chemotherapy for Hodgkin's disease), without Epstein-Barr virus infection stigmata in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236834     DOI: 10.1097/00000478-199707000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Hepatosplenic T-cell lymphoma.

Authors:  Fahad I Alsohaibani; Maheeba A Abdulla; Mousa M Fagih
Journal:  Indian J Hematol Blood Transfus       Date:  2011-02-12       Impact factor: 0.900

2.  Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

Authors:  Mariko Yabe; L Jeffrey Medeiros; Yahya Daneshbod; Masoud Davanlou; Carlos E Bueso-Ramos; Elisa J Moran; Ken H Young; Roberto N Miranda
Journal:  Ann Diagn Pathol       Date:  2016-10-18       Impact factor: 2.090

3.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

4.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

5.  Hepatosplenic T-cell lymphoma in a young immunocompetent man.

Authors:  Maja Petrova; Manuel Mendes Gomes; Jose Pedro Nascimento Carda; José Pereira de Moura
Journal:  BMJ Case Rep       Date:  2016-03-31

6.  Pituitary gland involvement by a gamma delta hepatosplenic lymphoma, a mimicker of pituitary adenoma: report of a rare case.

Authors:  D Jain; M C Sharma; C Sarkar; V Suri; A Garg; A K Mahapatra; L Kumar
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

Review 7.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266

Review 8.  Monitoring and safety of azathioprine therapy in inflammatory bowel disease.

Authors:  Mi Jin Kim; Yon Ho Choe
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-06-30

9.  Four hepatosplenic T-cell lymphoma cases of Japanese patients.

Authors:  Hidetsugu Kawai; Hiromichi Matsushita; Ken Ohmachi; Minoru Kojima; Shinichiro Machida; Yoshiaki Ogawa; Hiroshi Kawada; Naoya Nakamura; Kiyoshi Ando
Journal:  Leuk Res Rep       Date:  2015-12-15

Review 10.  Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas.

Authors:  Ibrahim N Muhsen; Riad El Fakih; Mehdi Hamadani; Hillard M Lazarus; Mohamed A Kharfan-Dabaja; Mahmoud Aljurf
Journal:  Clin Hematol Int       Date:  2022-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.